Free
Infographics in Anesthesiology  |   June 2015
Neuromuscular Blockade: Using Quantitative Monitoring to Get It Just Right
Author Affiliations & Notes
  • Jonathan P. Wanderer
    Vanderbilt University School of Medicine
  • James P. Rathmell
    Massachusetts General Hospital/Harvard Medical School
  • Illustration by Annemarie Johnson, Vivo Visuals.
    Illustration by Annemarie Johnson, Vivo Visuals.×
  • Dr. Wanderer is funded by the Foundation for Anesthesia Education and Research, Rochester, Minnesota, and Anesthesia Quality Institute’s Mentored Research Training Grant – Health Services Research, Schaumburg, Illinois.
    Dr. Wanderer is funded by the Foundation for Anesthesia Education and Research, Rochester, Minnesota, and Anesthesia Quality Institute’s Mentored Research Training Grant – Health Services Research, Schaumburg, Illinois.×
  • Address correspondence to Dr. Wanderer: jon.wanderer@vanderbilt.edu
Article Information
Infographics in Anesthesiology / Neuromuscular Diseases and Drugs / Neurosurgical Anesthesia / Technology / Equipment / Monitoring
Infographics in Anesthesiology   |   June 2015
Neuromuscular Blockade: Using Quantitative Monitoring to Get It Just Right
Anesthesiology 6 2015, Vol.122, A23. doi:10.1097/01.anes.0000464870.20675.e3
Anesthesiology 6 2015, Vol.122, A23. doi:10.1097/01.anes.0000464870.20675.e3
Complex Information for Anesthesiologists Presented Quickly and Clearly
NMBA = neuromuscular-blocking agent; OR = odds ratio; TOF = train of four.
Infographic created by Jonathan P. Wanderer, Vanderbilt University School of Medicine, and James P. Rathmell, Massachusetts General Hospital/Harvard Medical School. Illustration by Annemarie Johnson, Vivo Visuals. Dr. Wanderer is funded by the Foundation for Anesthesia Education and Research, Rochester, Minnesota, and Anesthesia Quality Institute’s Mentored Research Training Grant – Health Services Research, Schaumburg, Illinois. Address correspondence to Dr. Wanderer: jon.wanderer@vanderbilt.edu.
Naguib, M, Kopman, AF, Lien, CA, Hunter, JM, Lopez, A, Brull, SJ A survey of current management of neuromuscular block in the United States and Europe.. Anesth Analg. (2010). 111 110–9 [PubMed]
Brull, SJ, Murphy, GS Residual neuromuscular block: Lessons unlearned. Part II: Methods to reduce the risk of residual weakness.. Anesth Analg. (2010). 111 129–40 [Article] [PubMed]
Murphy, GS, Brull, SJ Residual neuromuscular block: Lessons unlearned. Part I: Definitions, incidence, and adverse physiologic effects of residual neuromuscular block.. Anesth Analg. (2010). 111 120–8 [Article] [PubMed]
McLean, DJ, Diaz-Gil, D, Farhan, HN, Ladha, KS, Kurth, T, Eikermann, M Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications.. Anesthesiology. (2015). 122 1201–13